title: [WAO Guideline for the Management of Hereditary Angioedema].
authors.affiliation: Department of Medicine, Pediatrics and Graduate Studies, Penn State University, Hershey, PA.
authors.forename: Timothy
authors.initials: T
authors.lastname: Craig
authors.forename: Emel Aygören
authors.initials: EA
authors.lastname: Pürsün
authors.forename: Konrad
authors.initials: K
authors.lastname: Bork
authors.forename: Tom
authors.initials: T
authors.lastname: Bowen
authors.forename: Henrik
authors.initials: H
authors.lastname: Boysen
authors.forename: Henriette
authors.initials: H
authors.lastname: Farkas
authors.forename: Anete
authors.initials: A
authors.lastname: Grumach
authors.forename: Constance H
authors.initials: CH
authors.lastname: Katelaris
authors.forename: Richard
authors.initials: R
authors.lastname: Lockey
authors.forename: Hilary
authors.initials: H
authors.lastname: Longhurst
authors.forename: William
authors.initials: W
authors.lastname: Lumry
authors.forename: Markus
authors.initials: M
authors.lastname: Magerl
authors.forename: Immaculada
authors.initials: I
authors.lastname: Martinez-Saguer
authors.forename: Bruce
authors.initials: B
authors.lastname: Ritchie
authors.forename: Alexander
authors.initials: A
authors.lastname: Nast
authors.forename: Ruby
authors.initials: R
authors.lastname: Pawankar
authors.forename: Bruce
authors.initials: B
authors.lastname: Zuraw
authors.forename: Marcus
authors.initials: M
authors.lastname: Maurer
mesh_terms: D000486:Allergy and Immunology / Q000458:organization & administration*; D054179:Angioedemas, Hereditary / Q000145:classification / Q000175:diagnosis* / Q000517:prevention & control / Q000628:therapy*; D065094:Bradykinin B2 Receptor Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D050718:Complement C1 Inhibitor Protein / Q000008:administration & dosage; D003613:Danazol / Q000008:administration & dosage / Q000009:adverse effects; D003937:Diagnosis, Differential; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007391:International Cooperation; D007610:Kallikreins / Q000037:antagonists & inhibitors; D008297:Male; D010347:Patient Care Planning; D010455:Peptides / Q000008:administration & dosage / Q000494:pharmacology; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011994:Recombinant Proteins; D012944:Social Support
chemical_list: D065094:Bradykinin B2 Receptor Antagonists; D050718:Complement C1 Inhibitor Protein; D010455:Peptides; D011994:Recombinant Proteins; C511194:ecallantide; D007610:Kallikreins; D003613:Danazol